BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5

Benzinga · 2d ago
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.